Overview
Schimke immuno-osseous dysplasia (SIOD) is a rare autosomal recessive disorder characterized by steroid-resistant nephrotic syndrome, immunodeficiency, and osseous dysplasia, primarily linked to mutations in the SMARCAL1 gene 1.Diagnosis
Clinical Features: Steroid-resistant nephrotic syndrome, immune deficiency, and bone dysplasia 1.
Genetic Testing: Identification of SMARCAL1 gene mutations 1.
Imaging: Cerebral MRI to assess for cerebellar defects or abnormalities, especially if neurological symptoms develop 2.Management
Supportive Care: Focus on managing nephrotic syndrome, immune deficiencies, and bone health with supportive therapies 1.
Immunotherapy: No specific drug classes or doses mentioned; individualized based on immune deficiency severity 1.
Renal Replacement Therapy: Consider dialysis or transplantation for end-stage renal disease 1.Special Populations
Pediatrics: Early recognition crucial due to multisystem involvement; consider SIOD in children with steroid-resistant nephrotic syndrome and bone dysplasia 1.
Neurological Monitoring: Regular cerebral imaging recommended in pediatric patients to detect potential cerebellar defects 2.Key Recommendations
Consider Schimke immuno-osseous dysplasia in the differential diagnosis for children presenting with steroid-resistant nephrotic syndrome and bone dysplasia (Evidence: Moderate 1).
Perform cerebral imaging early in the course of the disease and repeat if neurological symptoms evolve (Evidence: Weak 2).
Tailor management to address specific manifestations such as nephrotic syndrome and immune deficiency with supportive care measures (Evidence: Expert opinion 1).References
1 Basiratnia M, Fallahzadeh MH. Schimke immuno-osseous dysplasia. Saudi medical journal 2007. link
2 Dhillon AS, Chapman S, Milford DV. Cerebellar defect associated with Schimke immuno-osseous dysplasia. European journal of pediatrics 2001. link